$RLFTF Relief Therapeutics: Gilles Della Corte, new medical director
FRIDAY, 04.09.2020
The biotech company Relief Therapeutics has appointed Gilles Della Corte as medical director with immediate effect, the Geneva-based company announced on Friday.
Dr. Della Corte, a cardiologist, has more than 30 years of experience in the biotechnology sector.
Relief Therapeutics announced on Friday the appointment of Gilles Della Corte, M.D., as medical director, with immediate effect.
Dr. Della Corte, a cardiologist, has more than 30 years of experience in the biotechnology sector, including at Merck Serono, where he was responsible for development, from proof of concept to project lifecycle management in several pathological areas, including cardiology, rheumatology, oncology and endocrinology.
Earlier in his career, he also held positions of (cont'd)
https://www.agefi.com/home/entreprises/detail...98663.html
FRIDAY, 04.09.2020
The biotech company Relief Therapeutics has appointed Gilles Della Corte as medical director with immediate effect, the Geneva-based company announced on Friday.
Dr. Della Corte, a cardiologist, has more than 30 years of experience in the biotechnology sector.
Relief Therapeutics announced on Friday the appointment of Gilles Della Corte, M.D., as medical director, with immediate effect.
Dr. Della Corte, a cardiologist, has more than 30 years of experience in the biotechnology sector, including at Merck Serono, where he was responsible for development, from proof of concept to project lifecycle management in several pathological areas, including cardiology, rheumatology, oncology and endocrinology.
Earlier in his career, he also held positions of (cont'd)
https://www.agefi.com/home/entreprises/detail...98663.html
Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ
